Status:
COMPLETED
Transplantation of Bone Marrow Derived Mesenchymal Stem Cells in Affected Knee Osteoarthritis by Rheumatoid Arthritis
Lead Sponsor:
Royan Institute
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
10-65 years
Phase:
PHASE2
PHASE3
Brief Summary
Osteoarthritis of the knee is one of the most common causes of disability among elderly. Arthritis rheumatoid is an autoimmune disease which causes multi articular arthritis, such as knee osteoarthrit...
Detailed Description
In this study all eligible patients were randomly allocated into two study groups by a permuted block randomization method: group A (control group) received only routine medical therapies and placebo ...
Eligibility Criteria
Inclusion
- Age 18 to 65 years
- Body mass index (BMI) ≤30 kg/m2
- The presence of osteoarthritis based on MRI and American Rheumatism Association criteria since 6 months before invitation
Exclusion
- 1\. Response to routine treatment at last one year.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01873625
Start Date
October 1 2009
End Date
December 1 2011
Last Update
June 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royan Institute
Tehran, Iran